ReWalk Robotics (RWLK) Receiving Somewhat Positive News Coverage, Report Finds
Media stories about ReWalk Robotics (NASDAQ:RWLK) have trended somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ReWalk Robotics earned a news sentiment score of 0.11 on Accern’s scale. Accern also gave news stories about the medical device company an impact score of 47.2392615476796 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- ReWalk Robotics ($RWLK) Stock | Surging On VA News – Warrior Trading News (press release) (warriortradingnews.com)
- Trading Updates on Shares of Rewalk Robotics Ltd (RWLK) – Hayden Business Journal (haydenbusinessjournal.com)
- LeMaitre Vascular, Inc. (LMAT) registers a price change of -0.41% while ReWalk Robotics Ltd. (RWLK) finishes with a … – Stocks Gallery (stocksgallery.com)
- What’s Behind Rewalk Robotics Ltd (RWLK)’s Movement – FLBC News (flbcnews.com)
- Intersect ENT : Today’s Research Report Coverage on Medical Equipment Stocks — Lantheus, Intersect ENT, CHF Solutions, and ReWalk Robotics (4-traders.com)
A number of research analysts have recently issued reports on RWLK shares. Canaccord Genuity reiterated a “buy” rating on shares of ReWalk Robotics in a report on Monday, June 12th. Zacks Investment Research raised ReWalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price objective for the company in a research report on Thursday, May 11th. Finally, Oppenheimer Holdings, Inc. set a $4.00 price objective on ReWalk Robotics and gave the stock a “buy” rating in a research report on Friday, August 4th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $4.00.
Shares of ReWalk Robotics (NASDAQ RWLK) opened at 1.65 on Friday. The firm’s market cap is $35.88 million. The stock has a 50 day moving average price of $1.42 and a 200-day moving average price of $1.66. ReWalk Robotics has a 52-week low of $1.10 and a 52-week high of $6.50.
ReWalk Robotics (NASDAQ:RWLK) last released its earnings results on Thursday, August 3rd. The medical device company reported ($0.29) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.35) by $0.06. The company had revenue of $2.01 million during the quarter, compared to the consensus estimate of $1.71 million. ReWalk Robotics had a negative net margin of 389.13% and a negative return on equity of 528.26%. The company’s revenue was up 145.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.64) EPS. On average, equities analysts anticipate that ReWalk Robotics will post ($1.30) EPS for the current fiscal year.
In related news, major shareholder Scp Vitalife Partners (Israel) sold 9,271 shares of the business’s stock in a transaction dated Monday, June 26th. The shares were sold at an average price of $3.00, for a total transaction of $27,813.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jeff Dykan sold 37,030 shares of the business’s stock in a transaction dated Monday, June 26th. The shares were sold at an average price of $3.00, for a total transaction of $111,090.00. The disclosure for this sale can be found here. Insiders sold a total of 198,637 shares of company stock valued at $603,339 in the last three months. Insiders own 13.70% of the company’s stock.
About ReWalk Robotics
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
Receive News & Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.